For more than a decade, patients facing certain types of prostate cancer have been able to turn to Xtandi, the now-brand name of enzalutamide, a compound breakthrough developed in the lab of Michael ...
LOS ANGELES, September 30, 2026--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) will convene leading researchers, clinicians and industry experts at its 33rd Annual Scientific Retreat, October ...
NCI Researcher Presents Research on the Role of White Blood Cells in Bone Metastatic Prostate Cancer
The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune system can contribute to bone metastatic prostate cancer as part of their ...
The Prostate Cancer Foundation (PCF) today announced Mary-Ellen Taplin, MD, as the recipient of the 2026 PCF Women in Science Lifetime Achievement Award. Dr. Taplin is Professor of Medicine at Harvard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results